Long-term Follow-up for Prostate Cancer

Phase-Based Progress Estimates
Prostate Cancer+2 More
Long-term Follow-up - Other
Any Age
What conditions do you have?

Study Summary

This trial looks at how well patients with prostate cancer do after surgery, in the long term. The data may help answer clinical questions, and help with future studies on how to improve the quality of life for prostate cancer survivors.

Eligible Conditions
  • Prostate Cancer
  • Cancer Survivors

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

3 Primary · 0 Secondary · Reporting Duration: Up to 10 years

Up to 10 years
HRQL assessed using Expanded Prostate Cancer Index Composite
HRQL assessed using Sexual Health Inventory for Men
Incidence rates of the study end-points

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Supportive Care (long-term follow-up)
1 of 1
Experimental Treatment

2500 Total Participants · 1 Treatment Group

Primary Treatment: Long-term Follow-up · No Placebo Group · N/A

Supportive Care (long-term follow-up)Experimental Group · 5 Interventions: Long-term Follow-up, Questionnaire Administration, Educational Intervention, Laboratory Biomarker Analysis, Quality-of-Life Assessment · Intervention Types: Other, Other, Other, Other, Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: up to 10 years

Who is running the clinical trial?

City of Hope Medical CenterLead Sponsor
505 Previous Clinical Trials
2,246,486 Total Patients Enrolled
12 Trials studying Prostate Cancer
3,040 Patients Enrolled for Prostate Cancer
National Cancer Institute (NCI)NIH
12,991 Previous Clinical Trials
41,295,993 Total Patients Enrolled
533 Trials studying Prostate Cancer
499,833 Patients Enrolled for Prostate Cancer
Saro Armenian, DOPrincipal InvestigatorCity of Hope Medical Center

Eligibility Criteria

Age Any Age · Male Participants · 8 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have no history of other urologic cancer (e.g.
Note: Patients who develop recurrence while participating in the Prostate Cancer Survivorship Clinic will be referred back to their urologist and may resume participation in the Survivorship Clinic when deemed appropriate by their treating physician.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 30th, 2021

Last Reviewed: October 31st, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.